Skip to main content
. 2021 Aug 18;8:710676. doi: 10.3389/fmolb.2021.710676

FIGURE 2.

FIGURE 2

Santamarine harbors cancer-selective antiproliferative activity. (A) Cell viability of cancer cell lines (HeLa, HepG2, HL-60, and MDA-MB-231) and noncancerous cell lines (BEAS-2B and L02) after treatment with santamarine. The viability was detected by the MTT assay after cells were incubated with increasing concentrations of santamarine for 48 h (B) HeLa cell viability assays in 24, 48, and 72 h were carried out as in (A), with a range of concentrations of santamarine. The results of each cell line were normalized to untreated controls. (n = 3 biological replicates, data are mean ± s. d. **p < 0.01 vs. the BEAS-2B group in (A), and the control group in (B).